These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 25248240

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Frequency of BCR-ABL fusion transcripts in Iranian patients with chronic myeloid leukemia.
    Yaghmaie M, Ghaffari SH, Ghavamzadeh A, Alimoghaddam K, Jahani M, Mousavi SA, Irvani M, Bahar B, Bibordi I.
    Arch Iran Med; 2008 May; 11(3):247-51. PubMed ID: 18426313
    [Abstract] [Full Text] [Related]

  • 3. [A clinical and laboratory study of chronic myeloid leukemia with atypical BCR-ABL fusion gene subtypes].
    Gui X, Pan J, Qiu H, Cen J, Xue Y, Chen S, Shen H, Yao L, Zhang J, Wu Y, Chen Y.
    Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):210-4. PubMed ID: 24666486
    [Abstract] [Full Text] [Related]

  • 4. Comprehensive analysis of BCR/ABL variants in chronic myeloid leukemia patients using multiplex RT-PCR.
    Bennour A, Ouahchi I, Moez M, Elloumi M, Khelif A, Saad A, Sennana H.
    Clin Lab; 2012 Mar; 58(5-6):433-9. PubMed ID: 22783572
    [Abstract] [Full Text] [Related]

  • 5. Rare e14a3 (b3a3) BCR-ABL fusion in chronic myeloid leukemia in India: the threats and challenges in monitoring minimal residual disease (MRD).
    Vaniawala S, Acharya A, Parekh H, Mukhopadhyaya PN.
    Anal Cell Pathol (Amst); 2013 Mar; 36(3-4):85-92. PubMed ID: 24072036
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comprehensive analysis of BCR-ABL transcript types in Korean CML patients using a newly developed multiplex RT-PCR.
    Goh HG, Hwang JY, Kim SH, Lee YH, Kim YL, Kim DW.
    Transl Res; 2006 Nov; 148(5):249-56. PubMed ID: 17145570
    [Abstract] [Full Text] [Related]

  • 8. Prognostic Implication of BCR-ABL Fusion Transcript Variants in Chronic Myeloid Leukemia (CML) Treated with Imatinib. A First of Its Kind Study on CML Patients of Kashmir.
    Azad NA, Shah ZA, Pandith AA, Khan MS, Rasool R, Rasool J, Aziz SA.
    Asian Pac J Cancer Prev; 2018 Jun 25; 19(6):1479-1485. PubMed ID: 29936718
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Technical aspects and clinical applications of measuring BCR-ABL1 transcripts number in chronic myeloid leukemia.
    Foroni L, Gerrard G, Nna E, Khorashad JS, Stevens D, Swale B, Milojkovic D, Reid A, Goldman J, Marin D.
    Am J Hematol; 2009 Aug 25; 84(8):517-22. PubMed ID: 19544476
    [Abstract] [Full Text] [Related]

  • 14. Frequency of BCR-ABL fusion transcripts in Sudanese patients with chronic myeloid leukemia using real-time reverse transcription-polymerase chain reaction.
    Muddathir AM, Kordofani AA, Fadl-Elmula IM.
    Saudi Med J; 2013 Jan 25; 34(1):29-33. PubMed ID: 23299156
    [Abstract] [Full Text] [Related]

  • 15. [The monitoring of residual disease for chronic myelogenous leukemia patients treated with imatinib mesylate: detection of T315I mutation in ATP binding site of BCR/ABL gene].
    Miyanishi S, Umeki K, Hayashi T, Fukutsuka K, Okumura A, Kishimori C.
    Rinsho Byori; 2003 Oct 25; 51(10):1023-9. PubMed ID: 14653203
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Application of Real-time Quantitative PCR in Detecting Atypical BCR/ABL mRNA Transcripts in Chronic Myelocytic Leukemia].
    Zou Y, DU C, Chen HM, Guo FX, Cheng JB, Tang YY, Wu W, Xia CQ.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Aug 25; 25(4):1016-1021. PubMed ID: 28823261
    [Abstract] [Full Text] [Related]

  • 18. Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases.
    Vefring HK, Gruber FX, Wee L, Hovland R, Hjorth-Hansen H, Gedde Dahl T, Meyer P.
    Acta Haematol; 2009 Aug 25; 122(1):11-6. PubMed ID: 19641300
    [Abstract] [Full Text] [Related]

  • 19. [Effect of co-expressing M-bcr/abl and m-bcr/abl fusion gene transcripts on the clinical features of patients with chronic myelogenous leukemia at diagnosis].
    Meng WT, Liu T, Li JJ, Shi Q, Yu J, Cui X, Wu Y, Xiang B.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan 25; 37(1):97-100. PubMed ID: 16468653
    [Abstract] [Full Text] [Related]

  • 20. Molecular monitoring of BCR-ABL transcripts after allogeneic stem cell transplantation for chronic myeloid leukemia.
    Arpinati M, Tolomelli G, Bochicchio MT, Castagnetti F, Amabile M, Bandini G, Bonifazi F, Stanzani M, Rosti G, Martinelli G, Baccarani M.
    Biol Blood Marrow Transplant; 2013 May 25; 19(5):735-40. PubMed ID: 23333776
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.